EULAR Task Force Recommendations on Annual Cardiovascular Risk Assessment for Patients with Rheumatoid Arthritis: An Audit of the Success of Implementation in a Rheumatology Outpatient Clinic
Table 2
Traditional CVD risk factors, medication, and CVD comorbidities.
AC group ()
RegROC ()
value
Sex (male) (%)
151 (29.2)
208 (34.3)
0.05
Age years (median, IQR)
62.0 (53.0–70.0)
66.0 (52.8–70.0)
0.002
Disease duration in years (median, IQR)
7.0 (3.0–17.0)
7.0 (3.0–15.0)
0.10
MHAQ (mean ± SD)
0.47 ± 0.47
0.51 ± 0.53
0.13
CVD risk factors (mean ± SD)
Total cholesterol (mmol/L)
5.55 ± 1.19
5.42 ± 1.20
0.24
LDL-c (mmol/L)
3.32 ± 1.03
3.21 ± 1.00
0.27
HDL-c (mmol/L)
1.66 ± 0.50
1.69 ± 0.51
0.64
Triglycerides (mmol/L)
1.40 ± 0.74
1.49 ± 0.87
0.32
Systolic BP (mmHg)
137.2 ± 19.3
137.1 ± 20.1
0.96
Diastolic BP (mmHg)
82.1 ± 9.3
82.7 ± 11.1
0.49
Fasting glucose (mmol/L)
5.71 ± 1.64
5.75 ± 1.60
0.85
HbA1c (%)
5.71 ± 0.85
5.74 ± 0.83
0.79
Smoking (%)†
61/367 (16.6)
56/378 (14.8)
0.50
CVD risk assessment (mean ± SD)
10-year risk calculated by SCORE in %
4.00 ± 4.5
3.71 ± 3.48
0.64
CVD medication/comorbidities: (%)† : patients using medication/having CVD : patients with medication/CVD recorded
Statins
54/198 (27.3)
12/53 (22.6)
0.50
Antihypertensives
56/198 (28.3)
14/53 (26.4)
0.79
Hypertension
48/184 (26.1)
10/47 (21.3)
0.50
Angina pectoris
4/184 (2.2)
1/47 (2.1)
0.98
AMI
4/184 (2.2)
0/47 (0)
0.31
PCI/CABG
6/184 (3.3)
1/47 (2.1)
0.69
CVA
5/184 (2.7)
4/47 (8.5)
0.07
Premature familiar CVD
36/184 (19.6)
4/47 (8.5)
0.07
Presented as the fraction and percent in patients who had cardiovascular risk factors recorded. RegROC: regular rheumatology outpatient clinic, AC: arthritis clinic, MHAQ: Modified Health Assessment Questionnaire, CVD: Cardiovascular disease, AMI: acute myocardial infarction, PCI: percutaneous coronary intervention, CABG: coronary artery bypass graft surgery, CVA: cerebrovascular accident, CVD: cardiovascular disease, LDL-c: low-density lipoprotein cholesterol, HDL-c: high-density lipoprotein cholesterol, BP: blood pressure, HbA1c: glycated haemoglobin, and SCORE: systematic coronary risk evaluation.
